Dr Jammi Nagaraj Rao

Dr Jammi Nagaraj Rao

9 Articles Published | Follow:

By Publicly Endorsing a Commercial Drug, Did the Health Minister Cross a Line?

How ICMR and Others Spun Covaxin’s Phase 1 Trial Results Out of Context

India Has Gained Two Vaccines but Its Regulators Have Tarnished Indian Science

Four Months After Itolizumab ‘Trial’ and 9 Million Infections Later – No Progress

India Will Soon Have a Working Vaccine. We Must Start Now To Make It Work for All.

Russia’s Latest COVID-19 Vaccine Venture Cries Out for Greater Transparency

India: If People Lose Trust in a COVID-19 Vaccine, We Will Lose Everything

Itolizumab: Why Real-World Data Can’t Substitute Randomised Controlled Trials

Is Biocon’s Itolizumab Good News? Hard to Tell, Thanks to the Bad Science.